Former Advisory Panel Member
James Wu, MSc, MPH
Represented: Industry
Conflicts of Interest:
As of October 27, 2016:
- Amgen Inc., Employee
- Abbott Laboratories, Stock
- AbbVie, Stock
- Amgen, Inc., Stock
- Curis, Inc., Stock
- Merge Healthcare, Stock
- PDL BioPharma, Stock
- Peregrine Pharmaceuticals, Inc., Stock
- Sunesis Pharmaceuticals, Stock
- ISPOR, Member
- AMCP, Member
Wu served as a member of the Advisory Panel on Rare Disease from Fall 2015 - Spring 2018.